References
- 1Instutute for Health Metrics and Evaluation (IHME). Global Burden of Disease 2021: Findings from the GBD 2021 Study. Seattle, WA: IHME, 2024.
- 2Blacher J, Olié V, Gabet A, et al. Two-year prognosis and CVD prevention after acute coronary syndrome: The role of cardiac rehabilitation – a French nationwide study. Eur J Prev Cardiol. 2024;31:1939–1947. DOI: 10.1093/eurjpc/zwae194
- 3McMahon SR, Ades PA, Thompson PD. The role of cardiac rehabilitation in patients with heart disease. Trends Cardiovasc Med. 2017;27:420–425. DOI: 10.1016/j.tcm.2017.02.005
- 4Dibben G, Faulkner J, Oldridge N, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database of Systematic Reviews. 2021;11:CD001800. DOI: 10.1002/14651858.CD001800.pub4
- 5Kotseva K, Wood D, De Bacquer D, et al, on behalf of the EUROASPIRE investigators. Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey. Eur J Prev Cardiol. 2018;25:1242–1251. DOI: 10.1177/2047487318781359
- 6Kotseva K, Wood D, De Backer G, De Bacquer D, on behalf of the EUROASPIRE III Study Group. Use and effects of cardiac rehabilitation in patients with coronary heart disease: Results from the EUROASPIRE III survey. Eur J Prev Cardiol. 2013;20:817–26. DOI: 10.1177/2047487312449591
- 7Norekvål TM, Bale M, Bedane HK, Hole T, Ingul CB, Munkhaugen J. Cardiac rehabilitation participation within 6 months of discharge in 37 136 myocardial infarction survivors: A nationwide registry study. Eur J Prev Cardiol. 2024;31:1977–1980. DOI: 10.1093/eurjpc/zwad350
- 8Grace SL, Hagström E, Harrison AS, et al, on behalf of the ICRR Investigators. Cardiac rehabilitation registries around the globe: Current status and future needs. Eur J Prev Cardiol. 2024;31:e117–e121. DOI: 10.1093/eurjpc/zwae182
- 9McEvoy JW, Jennings C, Kotseva K, et al, on behalf of the INTERASPIRE Investigators. INTERASPIRE: An international survey of coronary patients; their cardiometabolic, renal and biomarker status; and the quality of preventive care delivered in all WHO regions: in partnership with the World Heart Federation, European Society of Cardiology, Asia Pacific Society of Cardiology, InterAmerican Society of Cardiology, and PanAfrican Society of Cardiology. Curr Cardiol Rep. 2021;23:136. DOI: 10.1007/s11886-021-01568-2
- 10McEvoy JW, Jennings C, Kotseva K, et al, on behalf of the INTERASPIRE Investigators. Variation in secondary prevention of coronary heart disease: The INTERASPIRE study. Eur Heart J. 2024;45:4184–196. DOI: 10.1093/eurheartj/ehae558
- 11Taylor RS, Dalal HM, McDonagh STJ. The role of cardiac rehabilitation in improving cardiovascular outcomes. Nat Rev Cardiol. 2022;19:180–194. DOI: 10.1038/s41569-021-00611-7
- 12Anderson L, Oldridge N, Thompson DR, et al. Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis. J Am Coll Cardiol. 2016;67:1–12. DOI: 10.1016/j.jacc.2015.10.044
- 13Mahmood A, Ray R, Bin Salam ST, et al. The effectiveness of cardiac rehabilitation programs in improving cardiovascular outcomes: Systematic review and meta-analysis. Cureus. 2024;16(10):
e72450 . DOI: 10.7759/cureus.72450 - 14Salzwedel A, Jensen K, Rauch B, et al. Effectiveness of comprehensive cardiac rehabilitation in coronary artery disease patients treated according to contemporary evidence based medicine: Update of the Cardiac Rehabilitation Outcome Study (CROS-II). Eur J Prev Cardiol. 2020;27:1756–1774. DOI: 10.1177/2047487320905719
- 15Mamataz T, Uddin J, Ibn Alam S, et al, ACROSS collaboration. Effects of cardiac rehabilitation in low-and middle-income countries: A systematic review and meta-analysis of randomised controlled trials. Prog Cardiovasc Dis. 2022;70:119–174. DOI: 10.1016/j.pcad.2021.07.004
- 16Pesah E, Turk-Adawi K, Supervia M, et al. Cardiac rehabilitation delivery in low/middle-income countries. Heart. 2019;105:1806–12. DOI: 10.1136/heartjnl-2018-314486
- 17Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227–3337. DOI: 10.1093/eurheartj/ehab484
- 18Van Halewijn G, Deckers J, Tay HY, van Domburg R, Kotseva K, Wood D. Lessons from contemporary trials of cardiovascular prevention and rehabilitation: A systematic review and meta-analysis. Int J Cardiol. 2017;232:294–303. DOI: 10.1016/j.ijcard.2016.12.125
- 19Taylor R, Fredericks S, Jones I, et al. Global perspectives on heart disease rehabilitation and secondary prevention: A scientific statement from the Association of Cardiovascular Nursing and Allied Professions, European Association of Preventive Cardiology, and International Council of Cardiovascular Prevention and Rehabilitation. Eur Heart J. 2023;44:2515–2525. DOI: 10.1093/eurheartj/ehad225
- 20Samayoa L, et al. Sex differences in cardiac rehabilitation enrollment: A meta-analysis. Can J Cardiology. 2014;30:793–800. DOI: 10.1016/j.cjca.2013.11.007
- 21Silva V, Vilela EM, Campos L. Suboptimal control of cardiovascular risk factors in myocardial infarction survivors in a cardiac rehabilitation program. Rev Port Cardiol. 2021;40:911–920. DOI: 10.1016/j.repce.2021.11.007
- 22Zheng X, Zheng Y, Ma J, et al. Effect of exercise-based cardiac rehabilitation on anxiety and depression in patients with myocardial infarction: A systematic review and meta-analysis. Heart & Lung. 2019;48:1–7. DOI: 10.1016/j.hrtlng.2018.09.011
- 23Grace SL, Kotseva K, Whooley MA. Cardiac rehabilitation: Under-utilized globally. Current Cardiology Reports. 2021;23:118. DOI: 10.1007/s11886-021-01543-x
- 24Turk-Adawi K, Supervia M, Lopez-Jimenez F, et al. Cardiac rehabilitation availability and density around the globe. EClinicalMedicine. 2019;13:31–45. DOI: 10.1016/j.eclinm.2019.06.007
- 25Global Health Data Exchange. Institute for Health Metrics and Evaluation. GBD results tool.
http://ghdx.healthdata.org/gbd-results-tool ; 2021.
